This randomized, double-blind, placebo matched to efzofitimod-controlled, study will evaluate the safety, tolerability, immunogenicity, pharmacokinetic (PK), and preliminary efficacy of multiple ascending doses of IV efzofitimod in participants with…
- Investigators
- Divya C Patel, Christopher Harden
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All